MedPath

LIVELUNG - Impact of CGA in Patients Diagnosed With Localized NSCLC Treated With SBRT

Recruiting
Conditions
Comprehensive Geriatric Assessment
Non-small Cell Lung Cancer
Stereotactic Body Radiotherapy
Interventions
Other: Comprehensive Geriatric Assessment
Registration Number
NCT05919641
Lead Sponsor
Odense University Hospital
Brief Summary

Older patients with non-small cell lung cancer (NSCLC) treated with stereotactic body radiation therapy (SBRT) often die from other causes than lung cancer due to age-related comorbidities. This national randomized study will include 130 patients throughout 5 Danish cancer centres and investigate if a comprehensive geriatric intervention (CGA) when added upfront to SBRT for patients with localized NSCLC will have an impact on quality of life (QoL), overall survival, physical functionality and unplanned hospital admissions.

If an upfront CGA improves patients' general health status, this study could lead to implementation of a CGA in standard clinical practice as well as further research on older patients receiving radiotherapy.

Detailed Description

Not available

Recruitment & Eligibility

Status
RECRUITING
Sex
All
Target Recruitment
130
Inclusion Criteria
  • Patients with cytologically or histologically proven non-small cell lung cancer
  • Stage T1-3N0M0
  • ≥ 70 years old
  • In a multidisciplinary setting the patient is considered medically inoperable, too frail for operation due to age and/or comorbidity or that the patient refuse surgery and therefore candidate for SBRT.
Read More
Exclusion Criteria
  • Missing histology/cytology
  • Another current malignancy
  • Higher staging at treatment planning
  • Not able to provide informed consent
  • Do not speak or understand Danish
Read More

Study & Design

Study Type
OBSERVATIONAL
Study Design
Not specified
Arm && Interventions
GroupInterventionDescription
+CGAComprehensive Geriatric AssessmentPatients randomised to undergo a Comprehensive Geriatric Assessment (CGA)
Primary Outcome Measures
NameTimeMethod
Quality of Life (EQ-5D)12 months

Questionnaire with 5 dimensions each with 5 (1-5) levels representing the health status of the patient and the patients self-rated health status on a scale from 0-100 (EQ VAS). The score of the 5 dimensions can be converted into a single index value 0-1 with higher values indicating poorer health status.

Secondary Outcome Measures
NameTimeMethod
Hand-grip strength12 months

Hand-grip strength measured in kilo using a JAMAR hand dynamometer

Quality of Life (EQ-5D)9 months

Questionnaire with 5 dimensions each with 5 (1-5) levels representing the health status of the patient and the patients self-rated health status on a scale from 0-100 (EQ VAS). The score of the 5 dimensions can be converted into a single index value 0-1 with higher values indicating poorer health status.

Unplanned Admissions12 months

Time to first unplanned admission

Timed-up-and-go (TUG)12 months

TUG consists of timing (seconds) a patient getting up from a chair from the sitting to the bipedal position, walking three meters, turning, returning, and sitting on the chair again

Overall Survival (OS)12 months

The time from treatment to death, regardless of disease recurrence

Chair-stand-test (CST)12 months

The CST involves recording the number of "stands" from a chair a person can complete in 30 seconds

Trial Locations

Locations (4)

Aarhus University Hospital

🇩🇰

Aarhus, Aarhus N, Denmark

Odense University Hospital

🇩🇰

Odense, Denmark

Rigshospitalet

🇩🇰

Copenhagen, Denmark

Vejle Hospital

🇩🇰

Vejle, Denmark

© Copyright 2025. All Rights Reserved by MedPath